BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 21370997)

  • 1. Transfusion rate and prevalence of unexpected red blood cell alloantibodies in women undergoing hysterectomy for benign disease.
    Thoestesen LM; Rasmussen KL; Lauszus FF; Hansen CT; Titlestad KE; Larsen R
    Acta Obstet Gynecol Scand; 2011 Jun; 90(6):636-41. PubMed ID: 21370997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Red blood cell alloantibody frequency, specificity, and properties in a population of male military veterans.
    Tormey CA; Fisk J; Stack G
    Transfusion; 2008 Oct; 48(10):2069-76. PubMed ID: 18631165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and specificities of red blood cell alloantibodies in transfused Ugandans with different diseases.
    Natukunda B; Schonewille H; van de Watering L; Brand A
    Vox Sang; 2010 Feb; 98(2):167-71. PubMed ID: 19708889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cesarean section: is pretransfusion testing for red cell alloantibodies necessary?
    Larsen R; Titlestad K; Lillevang ST; Thomsen SG; Kidholm K; Georgsen J
    Acta Obstet Gynecol Scand; 2005 May; 84(5):448-55. PubMed ID: 15842209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Red blood cell alloimmunization in sickle cell disease patients in Uganda.
    Natukunda B; Schonewille H; Ndugwa C; Brand A
    Transfusion; 2010 Jan; 50(1):20-5. PubMed ID: 19821949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coexistence of autoantibodies and alloantibodies to red blood cells due to blood transfusion.
    Ahrens N; Pruss A; Kähne A; Kiesewetter H; Salama A
    Transfusion; 2007 May; 47(5):813-6. PubMed ID: 17465945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alloimmunizations following blood transfusions.
    Hundrić-Haspl Z; Juraković-Loncar N; Grgicević D; Balija M
    Acta Med Croatica; 1994; 48(4-5):193-7. PubMed ID: 7534524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of HLA antibodies in transfused patients with and without red cell antibodies.
    Buetens O; Shirey RS; Goble-Lee M; Houp J; Zachary A; King KE; Ness PM
    Transfusion; 2006 May; 46(5):754-6. PubMed ID: 16686842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of alloimmunization and delayed hemolytic transfusion reactions in patients with sickle cell disease.
    Cox JV; Steane E; Cunningham G; Frenkel EP
    Arch Intern Med; 1988 Nov; 148(11):2485-9. PubMed ID: 3142382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and evaluation of false-negative antibody screens.
    Powers A; Chandrashekar S; Mohammed M; Uhl L
    Transfusion; 2010 Mar; 50(3):617-21. PubMed ID: 19951323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of new maternal alloantibodies after intrauterine transfusion for severe Rhesus disease.
    Watson WJ; Wax JR; Miller RC; Brost BC
    Am J Perinatol; 2006 Apr; 23(3):189-92. PubMed ID: 16586229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunohematologic study in 112 patients with myelodysplastic syndromes: 10-year analysis].
    Arriaga F; Bonanad S; Larrea L; de la Rubia J; López F; Sanz MA; Sanz G; Marty ML
    Sangre (Barc); 1995 Jun; 40(3):177-80. PubMed ID: 7570268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delayed and acute hemolytic transfusion reactions resulting from red cell antibodies and red cell-reactive HLA antibodies.
    Takeuchi C; Ohto H; Miura S; Yasuda H; Ono S; Ogata T
    Transfusion; 2005 Dec; 45(12):1925-9. PubMed ID: 16371045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinically significant red cell alloantibodies in patients with warm autoimmune hemolytic anemia.
    Haspl ZH; Tomicić M; Grgicević D
    Acta Med Croatica; 2001; 55(4-5):149-52. PubMed ID: 12398016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety in transfusion practices. Red cell compatibility testing issues.
    Shulman IA
    Clin Lab Med; 1992 Dec; 12(4):685-700. PubMed ID: 1286558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Red cell alloantibodies in Lao blood donors.
    Keokhamphoui C; Urwijitaroon Y; Kongphaly D; Thammavong T
    Southeast Asian J Trop Med Public Health; 2014 Jan; 45(1):194-7. PubMed ID: 24964670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Red cell immunization in beta thalassaemia major.
    Bhatti FA; Salamat N; Nadeem A; Shabbir N
    J Coll Physicians Surg Pak; 2004 Nov; 14(11):657-60. PubMed ID: 15530273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incomplete pretransfusion testing leads to surgical delays.
    McWilliams B; Yazer MH; Cramer J; Triulzi DJ; Waters JH
    Transfusion; 2012 Oct; 52(10):2139-44; quiz 2145. PubMed ID: 22348700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delayed hemolytic transfusion reaction due to anti-S antibody in patient with anti-Jk(a) autoantibody and multiple alloantibodies.
    Guastafierro S; Sessa F; Cuomo C; Tirelli A
    Ann Hematol; 2004 May; 83(5):307-8. PubMed ID: 15064858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional registry of patient alloantibodies: first-year experience.
    Schwickerath V; Kowalski M; Menitove JE
    Transfusion; 2010 Jul; 50(7):1465-70. PubMed ID: 20345565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.